The administration of supplemental oxygen is a cornerstone treatment in critically ill patients to prevent and resolve cellular hypoxia. Although oxygen therapy can be lifesaving on many occasions, its overzealous use may lead to supraphysiological levels of the Pao
2 (ie, hyperoxia), which is associated with deleterious outcomes. For example, in critically ill adults, arterial hyperoxia has been associated with increased mortality, most pronounced at extreme levels of Pao
2.
1,2 Detrimental effects of hyperoxia may derive from increased formation of reactive oxygen species, which damage biomolecules, or from its pulmonary and vascular complications, such as atelectasis and hyperoxemic vasoconstriction.
3-7